AP-251

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameAP-251
Drug Alias NameAP-251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPositron-emission tomography enhancers
TargetsCyclin-dependent kinase 5
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAestas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAestas Pharma Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A